graphic
News > Companies
Norplant makers to settle
August 26, 1999: 10:45 a.m. ET

Settlement over birth control device reportedly could total $50M
graphic
graphic graphic
graphic
NEW YORK (CNNfn) - American Home Products agreed Thursday to settle -- for a reported $50 million -- claims by at least 36,000 women who say they suffered severe side effects using the Norplant contraceptive device.
     Wyeth-Ayerst Laboratories, a unit of the Madison, N.J.-based drugmaker, said in a statement that the settlement "was purely a business decision." The company did not admit to any wrongdoing in announcing the settlement, which would end five years of lawsuits involving the birth control implant.
     The statement did not provide any financial details of the arrangement.
     The Dallas Morning News reported Thursday that the settlement would give each woman $1,500 if she filed suit before March 1, for a total of more than $50 million. That figure "is not too bad off" the actual settlement amount, a source familiar with the situation told CNNfn.com.
     Lawyers for the majority of the plaintiffs have already endorsed the settlement offer, the newspaper said.
     The plaintiffs claimed they suffered health problems including irregular menstrual bleeding, headaches, nausea and depression after using Norplant, a device that is injected into the arm to prevent pregnancy for about five years. The company said most of the plaintiffs experienced routine side effects described in the product's labeling.
     In its statement, Wyeth-Ayerst said it would continue to offer the product and said it would defend "any and all new lawsuits aggressively." The company says it has won three jury verdicts, more than 20 summary judgments before trials, and the dismissal of about 14,000 claims.
     "Our legal success has come at a steep price because lawsuits are time-consuming, expensive, and have a chilling effect on research," Wyeth-Ayerst President Joseph M. Mahady said. "Now that the courts have found these cases to be without merit, we can turn our attention back to providing contraceptive options for American women."
     More than 5 million women worldwide have used the device, including 1 million in the U.S., the company said. Norplant became available in the U.S. in 1991.
     American Home Products still faces thousands of lawsuits from people who took the diet drug combination known as "fen phen." Plaintiffs in those cases allege that the company withheld evidence that the medication could cause heart valve damage.
     American Home Products (AHP) shares slipped 5/8 to 47-3/16 in early Thursday trading.Back to top

  RELATED SITES

American Home Products


Note: Pages will open in a new browser window
External sites are not endorsed by CNNmoney




graphic


Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.